Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RO7310729 |
| Trade Name | |
| Synonyms | XmAb24306|RO-7310729|RO 7310729 |
| Drug Descriptions |
RO7310729 (XmAb24306) is a IL15 - IL15Ralpha complex fused to a bispecific Fc domain, that stimulates proliferation of NK cells and T-cells (NCI Thesaurus). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C170890 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + RO7310729 | Atezolizumab RO7310729 | 0 | 1 |
| Cevostamab + RO7310729 + Tocilizumab | Cevostamab RO7310729 Tocilizumab | 0 | 1 |
| Daratumumab + RO7310729 | Daratumumab RO7310729 | 0 | 1 |
| RO7310729 | RO7310729 | 0 | 1 |